Radauceanu A, Avignon A, Ribstein J, Monnier L
Department of Metabolic Diseases, CHU Lapeyronie, Montpellier, France.
Diabet Med. 1998 Mar;15(3):262-3. doi: 10.1002/(SICI)1096-9136(199803)15:3<262::AID-DIA552>3.0.CO;2-J.
The prognosis of cholesterol embolism is often poor, and no treatment is presently available. We report the use of a stable prostacyclin analogue in treating cholesterol embolism in a diabetic patient with arteriopathy. As a sole therapy, it improved cutaneous manifestations and pain, in parallel with an increased transcutaneous oxymetry. We think that prostacyclin analogues are novel candidates for the treatment of cholesterol embolism.